10x Genomics Ownership | Who Owns 10x Genomics?

Overview Forecast RevenueFinancials Chart Transcripts

10x Genomics Ownership Summary

10x Genomics is owned by 85.24% institutional investors, 2.16% insiders, and 12.59% retail investors. Fmr is the largest institutional shareholder, holding 11.14% of TXG shares. ARK Innovation ETF is the top mutual fund, with 7.00% of its assets in 10x Genomics shares.

TXG Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	10x Genomics	85.24%	2.16%	12.59%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Healthcare Information Services Stocks	40.75%	11.44%	47.80%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	13.45M	11.14%	$193.21M
Ark investment management	11.94M	9.89%	$171.52M
Vanguard group	10.93M	9.06%	$157.01M
Blackrock funding, inc. /de	6.77M	5.61%	$97.22M
Blackrock	6.39M	5.35%	$124.34M
Morgan stanley	5.77M	4.84%	$112.30M
Nikko asset management americas	5.71M	4.73%	$82.05M
Sumitomo mitsui trust	5.71M	4.73%	$82.05M
Ra capital management	3.28M	2.72%	$47.09M
Venrock management vi	2.11M	1.76%	$40.98M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Venrock management vi	2.11M	100.00%	$40.98M
Sands capital ventures	481.77K	1.50%	$6.92M
Ark investment management	11.94M	1.43%	$171.52M
Nikko asset management americas	5.71M	0.89%	$82.05M
Ra capital management	3.28M	0.63%	$47.09M
Numerai gp	157.79K	0.62%	$2.27M
Brown capital management	1.84M	0.61%	$26.48M
Birchview capital, lp	50.00K	0.59%	$718.00K
Pdt partners	354.96K	0.45%	$5.10M
Deerfield management company, l.p. (series c)	1.50M	0.41%	$21.50M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	3.28M	0.63%	3.28M
Assenagon asset management	1.83M	0.04%	1.83M
D. e. shaw	1.22M	0.01%	1.22M
Ark investment management	11.94M	1.43%	1.19M
Camber capital management lp	1.00M	0.33%	1.00M

Top Sellers

Holder	Shares	% Assets	Change
Generation investment management llp	-	-	-2.88M
T. rowe price investment management	-	-	-2.16M
Point72 asset management	-	-	-1.23M
Soleus capital management	-	-	-951.00K
Freshford capital management	-	-	-783.24K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	3.28M	0.63%	3.28M	$47.09M
Assenagon asset management	1.83M	0.04%	1.83M	$26.31M
D. e. shaw	1.22M	0.01%	1.22M	$17.50M
Camber capital management lp	1.00M	0.33%	1.00M	$14.36M
Bnp paribas arbitrage, snc	632.53K	0.01%	632.53K	$9.08M

Sold Out

Holder	Change
Concourse financial group securities	-3.00
Mather group, llc.	-4.00
Northwest investment counselors	-6.00
Princeton global asset management	-9.00
Rakuten securities	-10.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	264	-1.86%	102,915,574	-1.38%	85	1.14%	143	-10.06%	85	19.72%
Sep 30, 2024	267	1.14%	104,336,340	-0.97%	86	1.12%	157	8.28%	71	-7.79%
Jun 30, 2024	262	-10.58%	105,357,369	2.80%	88	1.20%	145	-14.71%	75	-
Mar 31, 2024	293	5.40%	102,484,018	6.88%	85	1.31%	170	9.68%	75	-9.64%
Dec 31, 2023	278	5.70%	95,888,619	5.44%	80	1.36%	155	37.17%	83	-17.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Innovation ETF	8.56M	7.00%	-82.02K
ARK Disruptive Innovation Full Composite	8.25M	6.82%	822.67K
Vanguard US Total Market Shares ETF	3.24M	2.65%	268.60K
Vanguard Total Stock Mkt Idx Inv	3.18M	2.60%	-
Nikko AM ARK Disruptive Innovation A USD	3.16M	2.59%	-63.45K
ARK Genomic Revolution ETF	2.90M	2.37%	111.86K
ARK Genomic Revolution	2.70M	2.23%	189.60K
Vanguard Small Cap Index	2.60M	2.12%	2.12K
Fidelity Growth Company Fund	2.10M	1.72%	-
Nikko AM ARK Pstv Chg Innovt P JPY Acc	2.02M	1.65%	-67.56K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 28, 2025	Saxonov Serge	Chief Executive Officer	Sell	$84.39K
Feb 24, 2025	Hindson Benjamin J.	See Remarks	Sell	$50.60K
Feb 24, 2025	Saxonov Serge	Chief Executive Officer	Sell	$56.35K
Feb 21, 2025	MATEO ALAN	-	Buy	$445.57K
Nov 22, 2024	Saxonov Serge	Chief Executive Officer	Sell	$91.61K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	1	3
2024 Q4	-	2
2024 Q3	-	3
2024 Q2	-	3
2024 Q1	-	9

TXG Ownership FAQ

Who Owns 10x Genomics?

10x Genomics shareholders are primarily institutional investors at 85.24%, followed by 2.16% insiders and 12.60% retail investors. The average institutional ownership in 10x Genomics's industry, Healthcare Information Services Stocks , is 40.75%, which 10x Genomics exceeds.

Who owns the most shares of 10x Genomics?

10x Genomics’s largest shareholders are Fmr (13.45M shares, 11.14%), Ark investment management (11.94M shares, 9.89%), and Vanguard group (10.93M shares, 9.06%). Together, they hold 30.09% of 10x Genomics’s total shares outstanding.

Does Blackrock own 10x Genomics?

Yes, BlackRock owns 5.35% of 10x Genomics, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 124.34M$. In the last quarter, BlackRock increased its holdings by 385.01K shares, a 6.41% change.

Who is 10x Genomics’s biggest shareholder by percentage of total assets invested?

Venrock management vi is 10x Genomics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 2.11M 10x Genomics shares, valued at 40.98M$.

Who is the top mutual fund holder of 10x Genomics shares?

ARK Innovation ETF is the top mutual fund holder of 10x Genomics shares, with 7.00% of its total shares outstanding invested in 8.56M 10x Genomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools